Article Details
Retrieved on: 2021-07-07 09:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... to jointly develop and commercialize its two clinical-stage monoclonal antibodies (AL001 and AL101) for treating neurodegenerative diseases.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here